Goldwind Science&Technology Co., Ltd. (XJNGF)
OTCMKTS · Delayed Price · Currency is USD
0.9400
+0.0472 (5.29%)
At close: Aug 8, 2025
Inozyme Pharma Market Cap
XJNGF has a market cap or net worth of $5.68 billion as of August 8, 2025. Its market cap has increased by 55.41% in one year.
Market Cap
5.68B
Enterprise Value
10.51B
Revenue
8.16B
Ranking
n/a
PE Ratio
20.51
Stock Price
$0.94
Market Cap Chart
Since December 26, 2007, XJNGF's market cap has decreased from 8.92B to 5.68B, a decrease of -36.31%. That is a compound annual growth rate of -2.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 5.68B | 3.70% |
Dec 31, 2024 | 5.48B | 29.11% |
Dec 29, 2023 | 4.24B | -31.52% |
Dec 30, 2022 | 6.19B | -40.77% |
Dec 31, 2021 | 10.46B | 15.08% |
Dec 31, 2020 | 9.09B | 33.21% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Thai Airways International Public Company | 11.18B |
Kuber Resources | 968.97M |
Steel Partners Holdings L.P. | 800.08M |
Entrepreneur Universe Bright Group | 541.83M |
Siem Industries | 449.83M |
Paul Mueller Company | 376.72M |
Mestek | 347.03M |
Scope Industries | 270.31M |